LS301-IT
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LS301-IT, covering 2025-10-16 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer [Phase 2]